Loading…
To amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
This bill allows for the refundability of a portion of the tax credit for increasing research activities for small businesses (gross receipts not exceeding $1 million) engaged in specified medical research. Under the Public Health Service Act, specified medical research means research with respect to qualified countermeasures (i.e., a drug, biological product, or device for preventing harm from any biological agent or from a condition that may result in adverse health consequences or death).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Taxation/Internal Revenue Code
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $790,191 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
2022 · fourth_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act S. 4293, the Pharmacy Benefit Manager Transparency Act. H.R. _, the Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies Funding Bill Notice Of Proposed Rulemaking (NPRM) On The Affordability Of Employer Coverage For Family Members Of Employees H.R. 7504, the Start-ups for Cures Act H.R. 7505, the More Cures Act
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act S. 4293, the Pharmacy Benefit Manager Transparency Act. H.R. _, the Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies Funding Bill Notice Of Proposed Rulemaking (NPRM) On The Affordability Of Employer Coverage For Family Members Of Employees H.R. 7504, the Start-ups for Cures Act H.R. 7505, the More Cures Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Taxation/Internal Revenue Code
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Client expense: $607,142 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
2022 · third_quarter · Taxation/Internal Revenue Code
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Client expense: $857,235 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
2022 · second_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act S. 4293, the Pharmacy Benefit Manager Transparency Act. H.R. _, the Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies Funding Bill Notice Of Proposed Rulemaking (NPRM) On The Affordability Of Employer Coverage For Family Members Of Employees H.R. 7504, the Start-ups for Cures Act H.R. 7505, the More Cures Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Taxation/Internal Revenue Code
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
Client expense: $857,235 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office